Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Joseph M. Keca
Observed names:
J.M. Keca,
Keca, J.M.
Observed institutions:
University Health Network,
University of Toronto,
Princess Margaret Cancer Centre
ORCID:
0000-0002-8934-105X
Observed ORCID:
0000-0002-8934-105X
OpenAlex ID:
A5042216784
Nanotexaphyrin: One‐Pot Synthesis of a Manganese Texaphyrin‐Phospholipid Nanoparticle for Magnetic Resonance Imaging
2016
·
Joseph M. Keca
, Juan Chen
, et al.
·
Angewandte Chemie International Edition
·
50
Evaluation of QSAR models for predicting mutagenicity: outcome of the Second Ames/QSAR international challenge project
2023
·
A. Furuhama
, A. Kitazawa
, et al.
·
SAR and QSAR in environmental research
·
29
PDF
Texaphyrin: From molecule to nanoparticle
2017
·
Joseph M. Keca
, Gang Zheng
·
Coordination Chemistry Reviews
·
16
Mixed and Matched Metallo‐Nanotexaphyrin for Customizable Biomedical Imaging
2018
·
Joseph M. Keca
, Michael S. Valic
, et al.
·
Advanced Healthcare Materials
·
10
Nanotexaphyrin: One‐Pot Synthesis of a Manganese Texaphyrin‐Phospholipid Nanoparticle for Magnetic Resonance Imaging
2016
·
Joseph M. Keca
, Juan Chen
, et al.
·
Angewandte Chemie
·
9
Texaphyrin Architectures for Biomedical Applications
2018
·
Joseph M. Keca
·
TSpace (University of Toronto)
·
1
PDF
Evaluation of QSAR models for predicting mutagenicity: outcome of the Second Ames/QSAR international challenge project
2023
·
Furuhama, A.
, Kitazawa, A.
, et al.
·
Figshare
Design and Synthesis of Small Molecule Agonists Targeting Type I Interferon and Vitamin D Receptors
2014
·
Joseph M. Keca
·
TSpace (University of Toronto)
PDF
Show more works
View as search
Works count:
8
Citation count:
115
H-index:
5
I10-index:
4
Year
Topic
Type
